Number of the records: 1  

Presence of Protease Inhibitor 9 and Granzyme B in Healthy and Pathological Human Corneas

  1. 1.
    SYSNO ASEP0567680
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitlePresence of Protease Inhibitor 9 and Granzyme B in Healthy and Pathological Human Corneas
    Author(s) Merjava, S.R. (CZ)
    Kössl, Jan (UEM-P)
    Neuwirth, Aleš (UMG-J) ORCID
    Skalická, P. (CZ)
    Hlinomazová, Z. (CZ)
    Holáň, Vladimír (UEM-P) RID
    Jirsová, K. (CZ)
    Article number793
    Source TitleBiology. - : MDPI
    Roč. 11, č. 5 (2022)
    Number of pages11 s.
    Languageeng - English
    CountryCH - Switzerland
    Keywordscornea ; corneal endothelium ; corneal epithelium ; protease inhibitor 9 ; granzyme B
    OECD categoryBiochemistry and molecular biology
    Method of publishingOpen access
    Institutional supportUEM-P - RVO:68378041 ; UMG-J - RVO:68378050
    UT WOS000801636700001
    EID SCOPUS85132543642
    DOI10.3390/biology11050793
    AnnotationSimple Summary Detailed knowledge of the structure and properties of the human cornea is a prerequisite not only for the treatment of various corneal diseases but also for successful corneal transplantation and its long-term survival after grafting. Using various cell and molecular biology approaches, we found in cornea the protease inhibitor 9. This protein, known to be present in other human tissues but not yet reported in cornea, is directly involved in the immune response after transplantation. Together with its inhibitor (granzyme B), we localized this protein, especially in the superficial and inner cornea layers. This localization indicates that protease inhibitor 9 protein may be involved in protecting the cornea from external damage, but also in protection against immune cells inducing corneal graft rejection. Furthermore, we have shown on pathological corneal samples from corneal melting and herpes virus keratitis that the increased expression of both proteins is linked to these diseases. These experiments and their results represent an important contribution to the basic research of cornea biological properties with direct overlap into clinical practice. The aim of this study was to find out whether protease inhibitor 9 (PI-9) and granzyme B (GrB) molecules that contribute to immune response and the immunological privilege of various tissues are expressed in healthy and pathological human corneas. Using cryosections, cell imprints of control corneoscleral discs, we showed that PI-9 was expressed particularly in the endothelium, the superficial and suprabasal epithelium of healthy corneas, limbus, and conjunctiva. GrB was localized in healthy corneal and conjunctival epithelium, while the endothelium showed weak immunostaining. The expression of PI-6 and GrB was confirmed by qRT-PCR. Increased expression levels of the PI-9 and GrB genes were determined when the corneas were cultured with proinflammatory cytokines. Fluorescent and enzymatic immunohistochemistry of pathological corneal explants (corneal melting and herpes virus keratitis) showed pronounced PI-9, GrB, human leucocyte antigen (HLA)-DR, and leukocyte-common antigen (CD45) signals localized in multicellular stromal infiltrates and inflammatory cells scattered in the corneal stroma. We conclude that increased expression of the PI-9 and GrB proteins under pathological conditions and their upregulation in an inflammatory environment indicate their participation in immune response of the cornea during the inflammatory process.
    WorkplaceInstitute of Experimental Medicine
    ContactLenka Koželská, lenka.kozelska@iem.cas.cz, Tel.: 241 062 218, 296 442 218
    Year of Publishing2023
    Electronic addresshttps://www.mdpi.com/2079-7737/11/5/793
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.